The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
Public ClinicalTrials.gov record NCT00002389. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Parallel-Group, Multicenter Trial to Evaluate the Safety and Efficacy of 1592U89 in Combination With Lamivudine (3TC) and Zidovudine (ZDV) Versus 3TC/ZDV in HIV-1-Infected, Antiretroviral Therapy-Naive Subjects With CD4+ Counts >= 100 Cells/mm3
Study identification
- NCT ID
- NCT00002389
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Glaxo Wellcome
- Industry
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Interventions
- Abacavir sulfate Drug
- Lamivudine Drug
- Zidovudine Drug
Drug
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Bay AIDS Ctr | Berkeley | California | 94705 | — |
| Kraus Med Partners | Los Angeles | California | 90036 | — |
| Georgetown Univ Med Ctr | Washington D.C. | District of Columbia | 20007 | — |
| Univ of Miami Dept of Medicine | Miami | Florida | 33136 | — |
| Rush Med College / Rush Presbyterian - St Luke's Med Cen | Chicago | Illinois | 60612 | — |
| Boston Med Ctr / Evans - 556 | Boston | Massachusetts | 021182393 | — |
| Saint Michael's Med Ctr / Dept of Infectious Diseases | Newark | New Jersey | 07102 | — |
| St Vincent's Hosp and Med Ctr / AIDS Ctr | New York | New York | 10011 | — |
| Harlem Hosp | New York | New York | 10027 | — |
| Duke Univ Med Ctr / Dept of Medicine | Durham | North Carolina | 27710 | — |
| Univ of Cincinnati / Holmes Hosp | Cincinnati | Ohio | 452670405 | — |
| Dr Nicholaos Bellos | Dallas | Texas | 75225 | — |
| Baylor College of Medicine / Dept of Medicine | Houston | Texas | 770303498 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002389, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002389 live on ClinicalTrials.gov.